Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

FDA Approves Xhance

Optinose Announces FDA Approval of Xhance (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps

Off-Roading Threat May Lurk in the Air

FRIDAY, Sept. 22, 2017 -- Falls arent the only danger for kids who ride an off-road vehicle. In many parts of the United States, riders may also inhale hazardous mineral fibers and toxic dust, researchers warn. Four-wheel-drive and all-terrain vehicles

Are Her Chocolate Cravings a Product of the Culture?

Are Her Chocolate Cravings a Product of the Culture?‘ FRIDAY, Aug. 25, 2017 -- While some U.S. women believe they need a dose of chocolate because their period is near, the culture they live in may be key to that impulse, new research suggests.

FDA Approves Gocovri

FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinsons Disease Patients EMERYVILLE, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (

FDA Approves Besponsa

FDA Approves Besponsa FDA Approves Besponsa (inotuzumab ozogamicin) for Relapsed or Refractory Acute Lymphoblastic Leukemia

Less is More for the Adult Cholera Vaccine

FRIDAY, Aug. 18, 2017 -- Researchers say one dose of cholera vaccine appears to provide about the same protection as the standard two doses, at least for the first six months. They also found that cholera vaccines are highly effective in adults but les